What is it about?
There is increasing appreciation of the individual differences among people with diabetes, with variable response to treatment and prognosis. This is particularly relevant for type 2 diabetes. In a brief report in this issue of Diabetes Care, a study from Michael Roden and colleagues has provided new insights regarding the clinical relevance of the clusters and the underlying pathophysiology. The study provides a good illustration of detailed characterisation, together with biomarkers analyses, can help uncover the complexity and heterogeneity of diabetes, and provide advances towards precision management of diabetes.
Featured Image
Read the Original
This page is a summary of: Unravelling Diabetes Endotypes and Associated Pathophysiology for Precision Medicine in Diabetes: Ready for Prime Time?, Diabetes Care, November 2025, American Diabetes Association,
DOI: 10.2337/dci25-0067.
You can read the full text:
Contributors
The following have contributed to this page







